Cameron Brennan

71.7k citations

158 papers · 22.3k indexed · 14 hit papers · h-index 67

Impact in

Genetics top 0.05%
- Glioma Diagnosis and Treatment
Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism

Papers in

Genetics 73
- Glioma Diagnosis and Treatment 72
- Genomic variations and chromosomal abnormalities 10
Cancer Research 46
- MicroRNA in disease regulation 19
- Cancer Genomics and Diagnostics 18

Co-authors: Lynda Chin Ronald A. DePinho Eric C. Holland Jason T. Huse Viviane Tabar Keith L. Ligon Robert D. Rafal Dolores Hambardzumyan
Journals: Cancer Research (11 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)Genes & Development (8 papers)Journal of Neuro-Oncology (7 papers)Proceedings of the National Academy of Sciences (7 papers)
Partner nations: United States Germany Canada

In The Last Decade

Cameron Brennan

154 papers receiving 22.0k citations

Hit Papers

14 papers align trajectories log scale

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease 2025 · 25 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Nature
2020 Cell
2016 Cell Reports
2013 Nature Medicine
2012 Nature Medicine
2012 Genes & Development
2012 Nature Genetics
2010 Nature
2009 Cell stem cell
2008 Nature
2007 Genes & Development
2007 Science
2004 Cancer Cell
1989 Journal of Experimental Psychology Human Perception & Performance

Peers

Countries citing papers authored by Cameron Brennan

Since Specialization

Citations

This map shows the geographic impact of Cameron Brennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron Brennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron Brennan more than expected).

Fields of papers citing papers by Cameron Brennan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron Brennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron Brennan. The network helps show where Cameron Brennan may publish in the future.

Co-authors

The 25 scholars most cited alongside Cameron Brennan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cameron Brennan Line = papers co-authored together Cameron Brennan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease Nature ·Viviane Tabar, Harini Sarva, Andrés M. Lozano, Alfonso Fasano, Suneil K. Kalia, Kenny Kwok Hei Yu, Cameron Brennan, Yilong Ma, Shichun Peng, David Eidelberg, D. John Arduini, Stefan Irion, 伊藤康男, N. Abid, Antoine Lampron, Lorenz Studer, Claire Henchcliffe Hit paper breakdown →	2025	25
2	Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-Month Results From a Phase 1 Study Parkinsonism & Related Disorders ·Alfonso Fasano, Claire Henchcliffe, Harini Sarva, Andrés M. Lozano, Suneil K. Kalia, Kun Yu, Cameron Brennan, 伊藤康男, N. Abid, T. P. Kuregm, Ahmed Enayetallah, Antoine Lampron, Viviane Tabar	2024	0
3	Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma Clinical Cancer Research ·Rena Dedefo Buta, Anusha Aditya, 储春荣, Feng Chen, Barney Yoo, Tianye Cao, Brian Madajewski, Rachel Lee, Melik Z. Turker, Kai Ma, Sébastien Monette, M. Kaplanian, Ramiro Díaz-Harris, Shutian Ruan, Michael Overholtzer, Pat Zanzonico, Charles M. Rudin, Cameron Brennan, Ulrich Wiesner, Michelle S. Bradbury	2022	14
4	Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry JCI Insight ·Luciano Galdieri, Arijita Jash, Olga Malkova, Diane D. Mao, Yan-Hong Cheng, Rached Omer Agwil, Amber Salter, Jian Campian, Kristen M. Naegle, Cameron Brennan, Hiroaki Wakimoto, Stephen T. Oh, Albert H. Kim, Milan G. Chheda	2021	20
5	Molecular Engineering of Ultrasmall Silica Nanoparticle–Drug Conjugates as Lung Cancer Therapeutics Clinical Cancer Research ·Brian Madajewski, Feng Chen, Barney Yoo, Melik Z. Turker, Kai Ma, Li Zhang, Yaolin Zhu, Rupa Juthani, Rena Dedefo Buta, Mithat Gönen, Charles M. Rudin, Ulrich Wiesner, Michelle S. Bradbury, Cameron Brennan	2020	17
6	Development of a gene expression–based prognostic signature for IDH wild-type glioblastoma Neuro-Oncology ·Radia Marie Johnson, Heidi Phillips, Carlos Bais, Cameron Brennan, Timothy F. Cloughesy, Anneleen Daemen, Ulrich Herrlinger, Robert B. Jenkins, Albert Lai, Christoph Mancao, Michael Weller, Wolfgang Wick, Richard Bourgon, Josep Garcia	2020	19
7	Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model Clinical Cancer Research ·Rupa Juthani, Brian Madajewski, Barney Yoo, Li Zhang, Yaolin Zhu, Feng Chen, Melik Z. Turker, Kai Ma, Michael Overholtzer, Valerie A. Longo, Sean Carlin, Rena Dedefo Buta, Jason T. Huse, Mithat Gönen, Pat Zanzonico, Charles M. Rudin, Ulrich Wiesner, Michelle S. Bradbury, Cameron Brennan	2019	71
8	Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients Cancer Research ·Vesselin Z. Miloushev, Kristin L. Granlund, Rostislav Boltyanskiy, Serge K. Lyashchenko, Lisa M. DeAngelis, Ingo K. Mellinghoff, Cameron Brennan, Nicholas Helle, Jonathan T. Yang, Andrei I. Holodny, Ramon E. Sosa, Yanwei Guo, Albert P. Chen, James Tropp, Fraser Robb, Kayvan R. Keshari	2018	176
9	CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer Cancer Research ·Taku Yoshida, Jee Hyun Kim, Kristopher Carver, Ying Su, Stanislawa Weremowicz, Xiani Yan, S Yamamoto, Cameron Brennan, Shenglin Mei, Henry W. Long, Jun Yao, Kornélia Polyák	2015	84
10	Suppression of MicroRNA-9 by Mutant EGFR Signaling Upregulates FOXP1 to Enhance Glioblastoma Tumorigenicity Cancer Research ·German G. Gomez, Stefano Volinia, Carlo M. Croce, Ciro Zanca, Ming Li, Ryan J. Emnett, David H. Gutmann, Cameron Brennan, Frank B. Furnari, Webster K. Cavenee	2014	61
11	Radiographic Features, Patterns of Treatment Failure, and Clinical Outcomes in 56 Cases of Molecularly Subtyped Glioblastoma Multiforme Patients International Journal of Radiation OncologyBiologyPhysics ·Quincey LaPlant, Kenneth L. Pitter, Robert J. Young, Yoshiya Yamada, Timothy A. Chan, Jason T. Huse, Cameron Brennan, Kathryn Beal	2014	1
12	Double Minute Chromosomes in Glioblastoma Multiforme Are Revealed by Precise Reconstruction of Oncogenic Amplicons Cancer Research ·Zack Sanborn, Sofie R. Salama, Mia Grifford, Cameron Brennan, Tom Mikkelsen, Suresh C. Jhanwar, Sol Katzman, Lynda Chin, David Haussler	2013	73
13	Candidate Pathways for Promoting Differentiation or Quiescence of Oligodendrocyte Progenitor-like Cells in Glioma Cancer Research ·Joseph D. Dougherty, Elena I. Fomchenko, I. Ibrahim, Eric F. Schmidt, Karim Y. Helmy, Elena Bazzoli, Cameron Brennan, Eric C. Holland, Ana Milosevic	2012	54
14	Recruited Cells Can Become Transformed and Overtake PDGF-Induced Murine Gliomas In Vivo during Tumor Progression PLoS ONE ·Elena I. Fomchenko, Joseph D. Dougherty, Karim Y. Helmy, Amanda Katz, Alexander Pietras, Cameron Brennan, Jason T. Huse, Ana Milosevic, Eric C. Holland	2011	59
15	Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies Science ·Jayne M. Stommel, Alec C. Kimmelman, Haoqiang Ying, Roustem Nabioullin, М. А. Pavlova, Ruprecht Wiedemeyer, Alexander H. Stegh, James E. Bradner, Keith L. Ligon, Cameron Brennan, Lynda Chin, Ronald A. DePinho Hit paper breakdown →	2007	699
16	Common and Distinct Genomic Events in Sporadic Colorectal Cancer and Diverse Cancer Types Cancer Research ·Eric S. Martin, Giovanni Tonon, Raktim Sinha, Yonghong Xiao, Bin Feng, Alec C. Kimmelman, Alexei Protopopov, Elena V. Ivanova, Cameron Brennan, Kate Montgomery, Raju Kucherlapati, Gerald Bailey, Mark Redston, Lynda Chin, Ronald A. DePinho	2007	54
17	Combined cDNA Array Comparative Genomic Hybridization and Serial Analysis of Gene Expression Analysis of Breast Tumor Progression Cancer Research ·Jun Yao, Stanislawa Weremowicz, Bin Feng, Robert Gentleman, Jeffrey R. Marks, Rebecca Gelman, Cameron Brennan, Kornélia Polyák	2006	133
18	A Genome-Wide Screen Reveals Functional Gene Clusters in the Cancer Genome and Identifies EphA2 as a Mitogen in Glioblastoma Cancer Research ·Fenghua Liu, Peter J. Park, Weil Lai, Elizabeth A. Maher, Arnab Chakravarti, Laura Durso, Xiuli Jiang, Ammer Mk, Belén Haza Gómez, Meredith Thomas, Lynda Chin, Cameron Brennan, Ronald A. DePinho, Isaac S. Kohane, Rona S. Carroll, Peter McL. Black, Mark D. Johnson	2006	94
19	Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities Cancer Research ·Elizabeth A. Maher, Cameron Brennan, Patrick Y. Wen, Laura Durso, Keith L. Ligon, Aaron Richardson, Deepak Khatry, Bin Feng, Raktim Sinha, David N. Louis, John Quackenbush, Peter McL. Black, Lynda Chin, Ronald A. DePinho	2006	140
20	High-Resolution Global Profiling of Genomic Alterations with Long Oligonucleotide Microarray Cancer Research ·Cameron Brennan, Yunyu Zhang, Christopher Leo, Bin Feng, A. Melissas, Andrew J. Aguirre, Minjung Kim, Alexei Protopopov, Lynda Chin	2004	101

About Cameron Brennan

Cameron Brennan is a scholar working on Genetics, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 158 papers that have together received 22.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (72 papers), Brain Metastases and Treatment (27 papers), MicroRNA in disease regulation (19 papers), Cancer Genomics and Diagnostics (18 papers), Meningioma and schwannoma management (13 papers), Genomic variations and chromosomal abnormalities (10 papers), Lung Cancer Research Studies (10 papers) and Cancer Cells and Metastasis (8 papers). The work is most often cited by research in Genetics (6.3k citations), Cancer Research (5.8k citations), Oncology (6.5k citations), Immunology (3.8k citations) and Molecular Biology (10.5k citations). Cameron Brennan has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Lynda Chin, Ronald A. DePinho, Eric C. Holland, Jason T. Huse, Viviane Tabar, Keith L. Ligon, Robert D. Rafal, Dolores Hambardzumyan, Tatsuya Ozawa and Peter A. Calabresi. Their work appears in journals such as Cancer Research, International Journal of Radiation Oncology*Biology*Physics, Genes & Development, Journal of Neuro-Oncology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact